SanRo Clinical Research Group

Bryant, Arkansas 72022

2 studies enrolling now · 4 studies all time

What they study most

Major Depressive Disorder, Schizophrenia, Type 2 Diabetes

Studies at this site

• A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3) — Recruiting now
• Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT) — Recruiting now
• A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder — Running, not enrolling
• A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor — Completed